Welsis Corp. (WLSS) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
701 E CATHEDRAL RD PHILADELPHIA, PA 19128 |
| State of Incorp. | WY |
| Fiscal Year End | September 30 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 6/30/2024 MRQ | 12/31/2023 MRQ | 9/30/2023 | 9/30/2022 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Other undisclosed current assets | 1 | 10 | 19 | |||
| Total current assets: | 1 | 10 | 19 | |||
| Noncurrent Assets | ||||||
| Intangible assets, net (including goodwill) | 21 | 23 | 31 | |||
| Intangible assets, net (excluding goodwill) | 21 | 23 | 31 | |||
| Total noncurrent assets: | 21 | 23 | 31 | |||
| TOTAL ASSETS: | 23 | 33 | 50 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 87 | 91 | 77 | |||
| Interest and dividends payable | ✕ | ✕ | ✕ | 4 | ||
| Accounts payable | 77 | 76 | 68 | |||
| Accrued liabilities | 9 | 16 | 4 | |||
| Other undisclosed accounts payable and accrued liabilities | ||||||
| Due to related parties | ✕ | ✕ | ✕ | 14 | ||
| Other undisclosed current liabilities | 27 | 20 | (4) | |||
| Total current liabilities: | 114 | 111 | 87 | |||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 40 | 40 | 40 | |||
| Long-term debt, excluding current maturities | 40 | 40 | 40 | |||
| Other undisclosed noncurrent liabilities | ||||||
| Total noncurrent liabilities: | 40 | 40 | 40 | |||
| Total liabilities: | 154 | 151 | 127 | |||
| Equity | ||||||
| Equity, attributable to parent | (131) | (118) | (77) | |||
| Common stock | 0 | 0 | 0 | |||
| Additional paid in capital | 23 | 23 | 23 | |||
| Accumulated deficit | (154) | (141) | (100) | |||
| Other undisclosed equity | (0) | |||||
| Total equity: | (131) | (118) | (77) | |||
| TOTAL LIABILITIES AND EQUITY: | 23 | 33 | 50 | |||
Income Statement (P&L) ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 TTM | 9/30/2023 | 9/30/2022 | ||
|---|---|---|---|---|---|
| Revenues | 14 | 16 | |||
| Gross profit: | 14 | 16 | |||
| Operating expenses | (60) | (57) | (43) | ||
| Operating loss: | (45) | (41) | (43) | ||
| Nonoperating income (Other Nonoperating income) | |||||
| Interest and debt expense | |||||
| Income (loss) from continuing operations: | (45) | (41) | (43) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (43) | |
| Net income (loss): | (45) | (41) | (43) | ||
| Other undisclosed net loss attributable to parent | |||||
| Net income (loss) available to common stockholders, diluted: | (45) | (41) | (43) | ||
Comprehensive Income ($ in thousands)
| 6/30/2024 TTM | 12/31/2023 TTM | 9/30/2023 | 9/30/2022 | ||
|---|---|---|---|---|---|
| Net income (loss): | (45) | (41) | (43) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | (45) | (41) | (43) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.